Papers by Valeriia Smialkovska
Frontiers in Genetics
Epigenetic clocks are the models, which use CpG methylation levels for the age prediction of an o... more Epigenetic clocks are the models, which use CpG methylation levels for the age prediction of an organism. Although there were several epigenetic clocks developed there is a demand for development and evaluation of the relatively accurate and sensitive epigenetic clocks that can be used for routine research purposes. In this study, we evaluated two epigenetic clock models based on the 4 CpG sites and 2 CpG sites in the human genome using the pyrosequencing method for their methylation level estimation. The study sample included 153 people from the Ukrainian population with the age from 0 to 101. Both models showed a high correlation with the chronological age in our study sample (R2 = 0.85 for the 2 CpG model and R2 = 0.92 for the 4 CpG model). We also estimated the accuracy metrics of the age prediction in our study sample. For the age group from 18 to 80 MAD was 5.1 years for the 2 CpG model and 4.1 years for the 4 CpG model. In this regard, we can conclude, that the models evaluat...
The Ukrainian Biochemical Journal, 2019
the phosphatidylinositol-3-kinase (PI3k)/mechanistic target of rapamycin complex 1 (mtorc1) signa... more the phosphatidylinositol-3-kinase (PI3k)/mechanistic target of rapamycin complex 1 (mtorc1) signaling pathway controls plenty of cellular functions regulating phosphorylation one of its mediators ribosomal protein S6 kinase 1 (S6k1). alternative translation of the common S6k1 transcript can generate three protein kinase isoforms, including p85-S6k1, p70-S6k1 and p60-S6k1. the catalytic activity of S6k1 is modulated by mitogens and growth factors via phosphorylation at three critical sites such as the activation loop (T-loop site), turn motif (TM site), and hydrophobic motif (HM site). Both members of the PI3K/mTORC1 pathway, PDk1 and mtorc1, directly phosphorylate the t-loop site and Hm site, respectively. Indeed, most studies aimed at elucidating S6k1 regulation have focused on p70-and p85-S6k1. meanwhile, however, the activity of p60-S6K1 and its regulation have not been elucidated so far. To test whether p60-S6K1 was an active kinase isoform that was regulated similar to p70/p85-S6k1, we employed previously generated p85-/p70-/ p60 + HEK-293 cells. First, an in vitro kinase assay confirmed the ability of p60-S6K1 to phosphorylate ribosomal protein S6 (rpS6), a well-known S6K1 substrate. Next, analysis of p60-S6K1 phosphorylation under different cell growth conditions showed that p60-S6K1 does not have detectable levels of phosphorylation at PDk1-and mtorc1-regulated sites, yet this isoform undergoes phosphorylation at the tm site. Finally, we found that activity of p60-S6K1 was not sensitive to mitogenic stimulation and cell treatment by potent inhibitor of the PI3K1/mTORC1-dependent signaling pathway rapamycin suggesting the existence of a PI3K/ mtorc1-independent mechanism of p60-S6k1 regulation in Hek-293. the data of the current study suggest that the p60-S6k1 isoform possesses intrinsic kinase activity that is independent of PI3k/mtorc1 signaling regulation in Hek-293 cells. What is more, modulation of p60-S6k1 activity via the PI3k/mtorc1 signaling pathway seems to be cell-type specific, since the p60-S6K1 isoform undergoes PDK1-and mTORC1-mediated phosphorylation in breast cancer cell line MCF-7.
Uploads
Papers by Valeriia Smialkovska